Shoulder Brightness on Ultrasound Could Indicate Diabetes
|
By MedImaging International staff writers Posted on 04 Dec 2018 |

Image: A displays the normal gradient of the deltoid muscle; B shows reversal in T2D patient. D: Deltoid, S: Supraspinatus, H: Humerus (Photo courtesy of RSNA).
Unusually bright (hyperechoic) ultrasound images of the deltoid muscle may be a warning sign of type 2 diabetes (T2D), according to a new study.
Researchers at Henry Ford Hospital (Detroit, MI, USA) compiled 137 shoulder ultrasounds from patients with T2D, including 13 with pre-diabetes; they also obtained 49 ultrasounds from obese patients without diabetes. The ultrasounds were shown to two musculoskeletal radiologists who were asked to classify the patients, based on the brightness of their shoulder muscle, into one of three categories: normal, suspected diabetes, and definite diabetes. A third musculoskeletal radiologist acted as an arbitrator when the other two disagreed.
Based on the shoulder ultrasounds, the radiologists correctly predicted diabetes in 70 of 79 patients (89%). Brightness on ultrasound was also an accurate predictor of pre-diabetes, with all 13 pre-diabetic patients assigned to either suspected or definite diabetes categories. The researchers suspect that the hyperechoic image is due to low or depleted levels of glycogen in the muscle, which are decreased in T2D patients by up to 65%. The study was presented at the annual meeting of the Radiological Society of North America (RSNA), held during November 2018 in Chicago (IL, USA).
“We weren't surprised that we had positive results, because the shoulder muscle on patients with diabetes looked so bright on ultrasound, but we were surprised at the level of accuracy. A lot of the patients weren't even aware that they were diabetic or pre-diabetic,” said senior author and study presenter musculoskeletal radiologist Steven Soliman, DO. “If we observe this in patients with pre-diabetes and diabetes, we can get them to exercise, make diet modifications and lose weight. If these interventions happen early enough, the patients may be able to avoid going on medications and dealing with all the complications that go with the disease.”
Glycogen is a multi-branched polysaccharide that forms the main storage form of glucose in the body. In humans, glycogen is made and stored primarily in the cells of the liver and skeletal muscle. Muscle cell glycogen appears to function as an immediate reserve source of available glucose for muscle cells. As muscle cells lack glucose-6-phosphatase, which is required to pass glucose into the blood, the glycogen they store is available solely for internal use and is not shared with other cells.
Related Links:
Henry Ford Hospital
Researchers at Henry Ford Hospital (Detroit, MI, USA) compiled 137 shoulder ultrasounds from patients with T2D, including 13 with pre-diabetes; they also obtained 49 ultrasounds from obese patients without diabetes. The ultrasounds were shown to two musculoskeletal radiologists who were asked to classify the patients, based on the brightness of their shoulder muscle, into one of three categories: normal, suspected diabetes, and definite diabetes. A third musculoskeletal radiologist acted as an arbitrator when the other two disagreed.
Based on the shoulder ultrasounds, the radiologists correctly predicted diabetes in 70 of 79 patients (89%). Brightness on ultrasound was also an accurate predictor of pre-diabetes, with all 13 pre-diabetic patients assigned to either suspected or definite diabetes categories. The researchers suspect that the hyperechoic image is due to low or depleted levels of glycogen in the muscle, which are decreased in T2D patients by up to 65%. The study was presented at the annual meeting of the Radiological Society of North America (RSNA), held during November 2018 in Chicago (IL, USA).
“We weren't surprised that we had positive results, because the shoulder muscle on patients with diabetes looked so bright on ultrasound, but we were surprised at the level of accuracy. A lot of the patients weren't even aware that they were diabetic or pre-diabetic,” said senior author and study presenter musculoskeletal radiologist Steven Soliman, DO. “If we observe this in patients with pre-diabetes and diabetes, we can get them to exercise, make diet modifications and lose weight. If these interventions happen early enough, the patients may be able to avoid going on medications and dealing with all the complications that go with the disease.”
Glycogen is a multi-branched polysaccharide that forms the main storage form of glucose in the body. In humans, glycogen is made and stored primarily in the cells of the liver and skeletal muscle. Muscle cell glycogen appears to function as an immediate reserve source of available glucose for muscle cells. As muscle cells lack glucose-6-phosphatase, which is required to pass glucose into the blood, the glycogen they store is available solely for internal use and is not shared with other cells.
Related Links:
Henry Ford Hospital
Latest Ultrasound News
- AI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
- Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
- New Ultrasound AI Tool Supports Rapid Prenatal Assessment
- New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
- Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
- Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
- AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery
- Portable Ultrasound Sensor to Enable Earlier Breast Cancer Detection
- Portable Imaging Scanner to Diagnose Lymphatic Disease in Real Time
- Imaging Technique Generates Simultaneous 3D Color Images of Soft-Tissue Structure and Vasculature
- Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
- Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
- Ultrasound Probe Images Entire Organ in 4D

- Disposable Ultrasound Patch Performs Better Than Existing Devices
- Non-Invasive Ultrasound-Based Tool Accurately Detects Infant Meningitis
- Breakthrough Deep Learning Model Enhances Handheld 3D Medical Imaging
Channels
Radiography
view channel
Simple Chest X-Ray Measure Predicts Survival After Lung Cancer Surgery
Obstructive ventilatory disorder, marked by airflow limitation that reduces breathing efficiency, increases postoperative risk in patients with lung cancer. Although surgery offers the best chance of cure,... Read more
AI Detection Tool Improves Identification of Lobular Breast Cancer
Breast cancer screening seeks early detection, yet some subtypes remain difficult to visualize on mammography, risking delayed diagnosis. On average, 1 in 20 women worldwide will develop breast cancer,... Read moreMRI
view channel
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read more
Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
Tricuspid regurgitation, in which blood flows back from the right ventricle into the right atrium, can lead to progressive right-sided heart failure. Clinicians need reliable ways to gauge severity and... Read moreNuclear Medicine
view channelMR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
Cardiac electrophysiology procedures are typically guided by X-ray fluoroscopy, which limits soft-tissue visualization and exposes patients and clinical staff to ionizing radiation. Real-time mapping that... Read more
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channelMultimodal AI Tool Combines CT and Health Records to Predict Heart Risk
Cardiovascular disease is a leading cause of death and an underrecognized risk for people treated for breast cancer. Cardiac complications can affect survival and quality of life. Clinicians need tools... Read more
AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer
Cervical cancer causes most of its global mortality in low- and middle-income countries, where radiotherapy capacity and specialist staff are limited. Treatment planning is labor-intensive and can delay... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







